tiprankstipranks
PTC Therapeutics (CH:P91)
:P91
Switzerland Market
P91
PTC Therapeutics
RESEARCH TOOLSreports

PTC Therapeutics (P91) Ratios

1 Followers

PTC Therapeutics Ratios

CH:P91's free cash flow for Q2 2026 was $0.94. For the 2026 fiscal year, CH:P91's free cash flow was decreased by $ and operating cash flow was $0.41. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 3.39 2.35 2.35 2.02 1.71
Quick Ratio
 3.28 2.27 2.31 1.97 1.65
Cash Ratio
 1.36 1.02 1.34 0.98 0.69
Solvency Ratio
 <0.01 0.23 -0.10 -0.14 -0.21
Operating Cash Flow Ratio
 -0.04 0.73 -0.19 -0.26 -0.88
Short-Term Operating Cash Flow Coverage
 -0.55 1.25 -0.42 -0.82 -4.94
Net Current Asset Value
$ -798.48M$ -830.13M$ -1.44B$ -1.50B$ -1.36B
Leverage Ratios
Debt-to-Assets Ratio
 0.21 0.93 1.45 1.18 0.86
Debt-to-Equity Ratio
 -4.21 -13.19 -2.25 -2.72 -4.21
Debt-to-Capital Ratio
 1.31 1.08 1.80 1.58 1.31
Long-Term Debt-to-Capital Ratio
 1.45 1.11 2.09 1.75 1.38
Financial Leverage Ratio
 -19.66 -14.12 -1.55 -2.32 -4.91
Debt Service Coverage Ratio
 0.84 1.21 -0.28 -0.81 -2.08
Interest Coverage Ratio
 0.63 5.63 -1.81 -3.40 -4.92
Debt to Market Cap
 0.11 0.43 0.68 1.02 0.49
Interest Debt Per Share
 10.62 35.95 34.33 31.51 21.64
Net Debt to EBITDA
 -2.04 1.94 -14.04 -4.95 -3.21
Profitability Margins
Gross Profit Margin
82.14%95.85%92.89%93.02%93.61%
EBIT Margin
11.72%49.05%-24.31%-60.45%-71.07%
EBITDA Margin
17.20%51.29%-14.93%-35.22%-52.63%
Operating Profit Margin
11.52%49.49%-37.50%-46.86%-64.03%
Pretax Profit Margin
-6.65%40.25%-45.01%-74.23%-84.07%
Net Profit Margin
-3.80%39.44%-45.03%-66.81%-80.00%
Continuous Operations Profit Margin
-3.80%39.44%-45.03%-66.81%-80.00%
Net Income Per EBT
57.22%97.99%100.05%90.02%95.15%
EBT Per EBIT
-57.70%81.33%120.01%158.39%131.31%
Return on Assets (ROA)
-1.18%23.55%-21.31%-33.05%-32.78%
Return on Equity (ROE)
21.72%-332.49%33.08%76.55%161.06%
Return on Capital Employed (ROCE)
4.69%44.37%-26.92%-34.00%-34.43%
Return on Invested Capital (ROIC)
2.61%33.37%-21.69%-26.32%-30.76%
Return on Tangible Assets
-1.39%28.12%-24.16%-43.70%-60.94%
Earnings Yield
-0.70%11.30%-10.47%-30.38%-20.42%
Efficiency Ratios
Receivables Turnover
 4.22 9.53 5.09 5.83 4.49
Payables Turnover
 4.45 1.58 3.32 10.83 1.64
Inventory Turnover
 1.97 0.90 2.47 2.14 2.05
Fixed Asset Turnover
 7.99 12.78 6.86 5.24 3.99
Asset Turnover
 0.31 0.60 0.47 0.49 0.41
Working Capital Turnover Ratio
 0.64 1.66 1.15 2.08 1.91
Cash Conversion Cycle
 189.61 212.07 109.38 199.33 36.67
Days of Sales Outstanding
 86.49 38.30 71.73 62.59 81.28
Days of Inventory Outstanding
 185.05 405.14 147.49 170.43 178.16
Days of Payables Outstanding
 81.93 231.38 109.85 33.69 222.77
Operating Cycle
 271.55 443.45 219.23 233.02 259.44
Cash Flow Ratios
Operating Cash Flow Per Share
 -0.37 8.94 -1.40 -2.12 -4.97
Free Cash Flow Per Share
 -4.01 5.17 -2.37 -3.73 -7.10
CapEx Per Share
 3.64 3.77 0.97 1.61 2.13
Free Cash Flow to Operating Cash Flow
 10.90 0.58 1.69 1.76 1.43
Dividend Paid and CapEx Coverage Ratio
 -0.10 2.37 -1.45 -1.31 -2.34
Capital Expenditure Coverage Ratio
 -0.10 2.37 -1.45 -1.31 -2.34
Operating Cash Flow Coverage Ratio
 -0.04 0.26 -0.04 -0.07 -0.24
Operating Cash Flow to Sales Ratio
 -0.03 0.41 -0.13 -0.17 -0.51
Free Cash Flow Yield
-6.03%6.81%-5.24%-13.53%-18.60%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -134.82 8.85 -9.54 -3.29 -4.90
Price-to-Sales (P/S) Ratio
 5.47 3.49 4.30 2.20 3.92
Price-to-Book (P/B) Ratio
 -33.16 -29.43 -3.16 -2.52 -7.89
Price-to-Free Cash Flow (P/FCF) Ratio
 -16.58 14.69 -19.07 -7.39 -5.38
Price-to-Operating Cash Flow Ratio
 -179.77 8.49 -32.21 -13.02 -7.68
Price-to-Earnings Growth (PEG) Ratio
 0.89 -0.03 0.22 -0.44 -1.01
Price-to-Fair Value
 -33.16 -29.43 -3.16 -2.52 -7.89
Enterprise Value Multiple
 29.74 8.75 -42.84 -11.19 -10.66
Enterprise Value
 5.16B 7.76B 5.16B 3.70B 3.92B
EV to EBITDA
 29.74 8.75 -42.84 -11.19 -10.66
EV to Sales
 5.12 4.49 6.40 3.94 5.61
EV to Free Cash Flow
 -15.52 18.88 -28.36 -13.25 -7.70
EV to Operating Cash Flow
 -169.16 10.92 -47.92 -23.34 -10.99
Tangible Book Value Per Share
 -7.84 -8.50 -16.91 -17.11 -15.83
Shareholders’ Equity Per Share
 -1.99 -2.58 -14.29 -10.94 -4.84
Tax and Other Ratios
Effective Tax Rate
 0.43 0.02 >-0.01 0.10 0.05
Revenue Per Share
 12.15 21.76 10.50 12.53 9.74
Net Income Per Share
 -0.46 8.58 -4.73 -8.37 -7.79
Tax Burden
 0.57 0.98 1.00 0.90 0.95
Interest Burden
 -0.57 0.82 1.85 1.23 1.18
Research & Development to Revenue
 0.43 0.26 0.66 0.71 0.93
SG&A to Revenue
 0.35 0.20 0.37 0.00 0.00
Stock-Based Compensation to Revenue
 0.08 0.04 0.09 0.14 0.16
Income Quality
 0.79 1.04 0.30 0.25 0.64
Currency in USD